Local siRNA delivery by non-viral vectors

Journal of Drug Delivery Science and Technology

Volumn 22, Issue 1, 2012, Pages 17-27

  Beilvert, F ^a,b   Mevel M ^a,b   Chatin B ^a,b   Pitard, B ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c IN CELL ART   (France)

Author keywords

Cationic lipid; Conjugated siRNA; Delivery; Intracerebral; Intraocular; Intratumoral; Local; Mucosal; Polymer; siRNA

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; AGN 211745; ALN RSV 01; CHITOSAN; LIPOFECTAMINE; PENETRATIN; PF 4523665; POLO LIKE KINASE 1; POLYMER; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BLADDER CANCER; CLINICAL TRIAL (TOPIC); CROHN DISEASE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUNTINGTON CHOREA; INFLUENZA; INNATE IMMUNITY; LIPOSOMAL DELIVERY; LUNG CANCER; METERED DOSE INHALER; NEBULIZER; NONHUMAN; PARAINFLUENZA VIRUS INFECTION; POWDER INHALER; PSORIASIS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; SEVERE ACUTE RESPIRATORY SYNDROME; ULCERATIVE COLITIS; VIRUS REPLICATION;

EID: 84857405001     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(12)50002-X     Document Type: Review

References (62)

1. Bitko V., Musiyenko A., Shulyayeva O., Barik S. - Inhibition of respiratory viruses by nasally administered siRNA. - Nat Med., 11, 50-55, 2005. (Pubitemid 40215837)
2. Jensen D.M., Cun D., Maltesen M.J., Frokjaer S., Nielsen H.M., Foged C. - Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation. - J. Control. Release, 142, 138-145, 2010.
3. Daviskas E., Anderson S.D., Brannan J.D., Chan H.K., Eberl S., Bautovich G. - Inhalation of dry-powder mannitol increases mucociliary clearance. - Eur. Respir. J., 10, 2449-2454, 1997. (Pubitemid 28048614)
4. Lam J.K., Liang W., Chan H.K. - Pulmonary delivery of therapeutic siRNA. - Adv. Drug Deliv. Rev., 2011.
5. Bivas-Benita M., Zwier R., Junginger H.E., Borchard G. - Non-invasive pulmonary aerosol delivery in mice by the endotracheal route. - Eur. J. Pharm. Biopharm., 61, 214-218, 2006. (Pubitemid 41427629)
6. Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. - 'Green mice' as a source of ubiquitous green cells. - FEBS Lett., 407, 313-319, 1997. (Pubitemid 27199450)
7. Beyerle A., Braun A., Merkel O., Koch F., Kissel T., Stoeger T. - Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice. - J. Control. Release, 151 (1), 51-56, 2011.
8. Eguchi A., Dowdy S.F. - Efficient siRNA delivery by novel PTD-DRBD fusion proteins. - Cell Cycle, 9, 424-425, 2010.
9. Akinc A., Zumbuehl A., Goldberg M., Leshchiner E.S., Busini V., Hossain N. et al. - A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. - Nat. Biotechnol., 26, 561-569, 2008. (Pubitemid 351668042)
10. Kuiken T., Fouchier R.A., Schutten M., Rimmelzwaan G.F., van Amerongen G., van Riel D. et al. - Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. - Lancet, 362, 263-270, 2003. (Pubitemid 36936836)
11. Zheng B.J., Guan Y., Tang Q., Du C., Xie F.Y., He M.L et al. - Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus. - Antivir.Ther., 9, 365-374, 2004. (Pubitemid 38878752)
12. Li B.J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q. et al. - Using siRNA in prophylactic and therapeutic regimens against SARS Coronavirus in Rhesus macaque. - Nat. Med., 11, 944-951, 2005. (Pubitemid 41294439)
13. Ge Q., Filip L., Bai A., Nguyen T., Eisen H.N., Chen J. - Inhibition of influenza virus production in virus-infected mice by RNA interference. - Proc. Natl. Acad. Sci. USA, 101: 8676-81, 2004. (Pubitemid 38745830)
14. Ge Q., McManus MT, Nguyen T., Shen C.H., Sharp P.A., Eisen H.N. et al. - RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. - Proc. Natl. Acad. Sci. USA, 100, 2718-2723, 2003. (Pubitemid 36297565)
15. Tompkins S.M., Lo C.Y., Tumpey T.M., Epstein S.L.- Protection against lethal influenza virus challenge by RNA interference in vivo. - Proc. Natl. Acad. Sci. USA, 101, 8682-8686, 2006.
16. Gautschi O., Betticher D.C. - Molecular therapy in lung cancer. - Ther. Umsch., 61, 365-371, 2004.
17. Xu C.X., Jere D., Jin H., Chang S.H., Chung Y.S., Shin J.Y. et a/. - Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. - Am. J. Respir. Crit. Care Med., 178, 60-73, 2008.
18. Tehrani A.M., Hwang S.K., Kim T.H., Cho C.S., Hua J., Nah W.S. et al. - Aerosol delivery of Akt controls protein translation in the lungs of dual luciferase reporter mice. - Gene Ther., 14, 451-458, 2007.
19. Moschos S.A., Jones S.W., Perry M.M., Williams A.E., Erjefalt J.S., Turner J.J. et al. - Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. - Bioconjug. Chem., 18, 1450-1459, 2007. (Pubitemid 47464052)
20. Saklatvala J. - The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. - Curr. Opin. Pharmacol., 4, 372-377, 2004. (Pubitemid 38987064)
21. Aouadi M., Tesz G.J., Nicoloro S.M., Wang M., Chouinard M., Soto E. et al. - Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. - Nature, 458, 1180-1184, 2009.
22. Wesche-Soldato D.E., Chung C.S., Lomas-Neira J., Doughty L.A., Gregory S.H., Ayala A. - In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. - Blood, 106, 2295-2301, 2005. (Pubitemid 41510799)
23. Soutschek J., Akinc A., Bramlage B., Charisse K., Constien R., Donoghue M. et al. - Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. - Nature, 432, 173-178, 2004. (Pubitemid 39545841)
24. Wilson D.S., Dalmasso G., Wang L., Sitaraman S.V., Merlin D., Murthy N. - Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines. - Nat. Mater., 9, 923-928, 2010.
25. Kriegel C., Amiji M. - Oral TNF-alpha gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease. - J. Control. Release, 150, 77-86, 2011.
26. Palliser D., Chowdhury D., Wang Q.Y., Lee S.J., Branson R.T., Knipe D.M. et al. - An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. - Nature, 439, 89-94, 2006. (Pubitemid 43053634)
27. Breunig M., Lungwitz U., Liebl R., Goepferich A. - Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. - Proc. Natl. Acad. Sci. USA, 104, 14454-14459, 2007. (Pubitemid 350003282)
28. Lv H., Zhang S., Wang B., Cui S., Yan J. - Toxicity of cationic lipids and cationic polymers in gene delivery. - J. Control. Release, 114, 100-199, 2006.
29. Li S., Rizzo M.A., Bhattacharya S., Huang L. - Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. - Gene Ther., 5, 930-937, 1998. (Pubitemid 28371910)
30. Zhang J.S., Liu F., Huang L. - Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. - Adv. Drug Deliv. Rev., 57, 689-698, 2005. (Pubitemid 40332597)
31. Woodrow K.A., Cu Y., Booth C.J., Saucier-Sawyer J.K., Wood M.J., Saltzman W.M. - Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. - Nat. Mater., 8, 526-533, 2009.
32. Wu S.Y., Chang H.I., Burgess M., McMillan N.A. - Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system. - J. Control. Release, 155 (3), 418-426, 2011.
33. Wu Y, Navarro F., Lal A., Basar E., Pandey R.K., Manoharan M. ef al. - Durable protection from Herpes Simplex Virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene. - Cell Host Microbe, 5, 84-94, 2009.
34. Nogawa M., Yuasa T., Kimura S., Tanaka M., Kuroda J., Sato K. et al. - Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. - J. Clin. Invest., 115, 978-985, 2005. (Pubitemid 40489402)
35. Holtrich U., Wolf G., Brauninger A., Karn T., Bohme B., Rubsamen-Waigmann H. et al. - Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. - Proc. Natl. Acad. Sci. USA, 91, 1736-1740, 1994. (Pubitemid 24080280)
36. Hassani Z., Lemkine G.F., Erbacher P., Palmier K., Alfama G., Giovannangeli C. et al. - Lipid-mediated siRNA delivery downregulates exogenous gene expression in the mouse brain at picomolar levels. - J. Gene Med., 7, 198-207, 2005. (Pubitemid 40348024)
37. Cardoso A.L., Simoes S., de Almeida L.P., Plesnila N., Pedroso de Lima M.C., Wagner E. et al. -Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS. - J. Control. Release, 132, 113-123, 2008.
38. Wang Y.L., Liu W., Wada E., Murata M., Wada K., Kanazawa I. - Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA. - Neurosci. Res., 53, 241-249, 2005. (Pubitemid 41463777)
39. Shen J.S., Watabe K., Ohashi T., Eto Y. - Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements. - GeneTher., 8, 1081-1087, 2001. (Pubitemid 32962705)
40. DiFiglia M., Sena-Esteves M., Chase K., Sapp E., Pfister E., Sass M. et al. - Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. - Proc. Natl. Acad. Sci. USA, 104, 17204-17209, 2007. (Pubitemid 350211015)
41. Uno Y., Piao W., Miyata K., Nishina K., Mizusawa H., Yokota T. - High-density lipoprotein facilitates in vivo delivery of alpha-tocopherol- conjugated short-interfering RNA to the brain. - Hum. Gene Ther., 22 (6), 711-719, 2011.
42. Thakker D.R., Natt F., Husken D., Maier R., Muller M., van der Putten H. et al. - Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. - Proc. Natl. Acad. Sci. USA, 101, 17270-17275, 2004. (Pubitemid 39627809)
43. Tan P.H., Yang L.C., Shih H.C., Lan K.C., Cheng J.T. - Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. - Gene Ther., 12, 59-66, 2005.
44. Kaiser P.K., Symons R.C., Shah S.M., Quinlan E.J., Tabandeh H., Do D.V. et al. - RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. - Am J. Ophthalmol., 150, 33-39 e2, 2010.
45. Kim B., Tang Q., Biswas P.S., Xu J., Schiffelers R.M., Xie F.Y. et al. - Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. - Am. J. Pathol., 165, 2177-2185, 2004. (Pubitemid 39578394)
46. Murata M., Takanami T., Shimizu S., Kubota Y., Horiuchi S., Habano W. et al. - Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF). - Curr. Eye Res., 31, 171-180, 2006.
47. Kleinman M.E., Yamada K., Takeda A., Chandrasekaran V., Nozaki M., Baffi J.Z. et al. - Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. - Nature, 452, 591-597, 2008. (Pubitemid 351483358)
48. Oh Y.K., Park T.G. - siRNA delivery systems for cancer treatment. - Adv. Drug Deliv. Rev., 61, 850-862, 2009.
49. Bisanz K., Yu J., Edlund M., Spohn B., Hung M.C., Chung L.W. et al. - Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model. - Mol. Ther., 12, 634-643, 2005. (Pubitemid 41350144)
50. Yoshizawa T., Hattori Y., Hakoshima M., Koga K., Maitani Y. - Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts. - Eur. J. Pharm. Biopharm., 70, 718-725, 2008.
51. Grzelinski M., Urban-Klein B., Martens T., Lamszus K., Bakowsky U., Hobel S. et al. - RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. - Hum. Gene Ther., 17, 751-766, 2006. (Pubitemid 44100720)
52. Kim S.H., Jeong J.H., Lee S.H., Kim S.W., ParkT.G. - Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. - J. Control. Release, 129, 107-116, 2008.
53. Zhu H., Liang Z.Y., Ren X.Y., Liu T.H. - Small interfering RNAs targeting mutant K-ras inhibit human pancreatic carcinoma cells growth in vitro and in vivo. - Cancer Biol. Ther., 5, 1693-1698, 2006.
54. Ripka S., Neesse A., Riedel J., Bug E., Aigner A., Poulsom R. et al. - CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer. - Gut, 59, 1101-1110, 2010.
55. Yamato K., Yamada T., Kizaki M., Ui-Tei K., Natori Y., Fujino M. et al. - New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. - Cancer Gene Ther., 15, 140-153, 2008. (Pubitemid 351240669)
56. Takei Y., Kadomatsu K., Yuzawa Y., Matsuo S., Muramatsu T. - A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. - Cancer Res., 64, 3365-3370, 2004. (Pubitemid 38657905)
57. Han H.D., Mora E.M., Roh J.W., Nishimura M., Lee S.J., Stone R.L. et al. - Chitosan hydrogel for localized gene silencing. - Cancer Biol. Ther., 11, 839-845, 2011.
58. Crombez L., Morris M.C., Dufort S., Aldrian-Herrada G., Nguyen Q., Mc Master G. et al. - Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. - Nucleic Acids Res., 37, 4559-4569, 2009.
59. Desigaux L., Sainlos M., Lambert O., Chevre R., Letrou-Bonneval E., Vigneron J.P. et al. - Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference. - Proc. Natl. Acad. Sci. USA, 104, 16534-16539, 2007. (Pubitemid 350211053)
60. Nielsen E.J., Nielsen J.M., Becker D., Karlas A., Prakash H., Glud S.Z. et al. - Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticles. - Pharm. Res., 27, 2520-2527, 2010.
61. Howard K.A., Rahbek U.L., Liu X., Damgaard C.K., Glud S.Z., Andersen M.O. et al. - RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. - Mol. Ther., 14, 476-484, 2006. (Pubitemid 44296092)
62. Fujii T., Saito M., Iwasaki E., Ochiya T., Takei Y., Hayashi S. ef al. - Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. - Int. J. Oncol., 29, 541-548, 2006.